Identification of 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitors

Bioorganic & Medicinal Chemistry Letters
2020.0

Abstract

The identification of a novel series of DprE1 inhibitors based on a 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamide scaffold is described herein. SAR exploration around the HTS hit 1 led to the identification of multiple analogues with potent DprE1 inhibition and good whole-cell antimycobacterial activity.

Knowledge Graph

Similar Paper

Identification of 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2020.0
Identification and Profiling of Hydantoins—A Novel Class of Potent Antimycobacterial DprE1 Inhibitors
Journal of Medicinal Chemistry 2018.0
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity
ACS Medicinal Chemistry Letters 2019.0
Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities
Journal of Medicinal Chemistry 2021.0
Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-<scp>d</scp>-Ribose Oxidase (DprE1) Inhibitors
Journal of Medicinal Chemistry 2020.0
Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones
European Journal of Medicinal Chemistry 2018.0
4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity
Journal of Medicinal Chemistry 2014.0
Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity
Journal of Medicinal Chemistry 2014.0
Mycobacterium tuberculosis Decaprenylphosphoryl-β-<scp>d</scp>-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity
Journal of Medicinal Chemistry 2020.0
Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides
European Journal of Medicinal Chemistry 2015.0